SwePub
Sök i LIBRIS databas

  Utökad sökning

WFRF:(Jedenius Erik)
 

Sökning: WFRF:(Jedenius Erik) > Patients' perspecti...

Patients' perspectives on three-monthly administration of antipsychotic treatment with paliperidone palmitate : A qualitative interview study

Rise, Marit B. (författare)
NTNU - Norges teknisk-naturvitenskapelige universitet, Norway,Department of Mental Health, Norwegian University of Science and Technology, Trondheim, Norway
Stølan, Liv Os (författare)
Psykiatrisk Center Sct. Hans, Denmark,Competence Centre for Forensic Psychiatry, Mental Health Centre Sct. Hans, Roskilde, Denmark
Erdner, Anette, 1946- (författare)
Ersta Sköndal Bräcke högskola,Institutionen för vårdvetenskap,Department of Health Care Sciences, Ersta Sköndal Bräcke University, Stockholm, Sweden
visa fler...
Hedberg, Berith, 1951- (författare)
Jönköping University,The Jönköping Academy for Improvement of Health and Welfare,HHJ. IMPROVE (Improvement, innovation, and leadership in health and welfare)
Stahl, Katja (författare)
Medical Department, Janssen Cilag AS Norway, Oslo, Norway
Riise, Jesper (författare)
Medical Department, Janssen Cilag AS Denmark, Birkerød, Denmark
Jedenius, Erik (författare)
Janssen Cilag AS, Denmark,Medical Department, Janssen Cilag AS Sweden, Stockholm, Sweden
Møllerhøj, Jette (författare)
Psykiatrisk Center Sct. Hans, Denmark,Competence Centre for Forensic Psychiatry, Mental Health Centre Sct. Hans, Roskilde, Denmark
visa färre...
 (creator_code:org_t)
2020-11-05
2021
Engelska.
Ingår i: Nordic Journal of Psychiatry. - : Informa UK Limited. - 0803-9488 .- 1502-4725. ; 75:4, s. 257-265
  • Tidskriftsartikel (refereegranskat)
Abstract Ämnesord
Stäng  
  • INTRODUCTION: Three-monthly dosage of paliperidone palmitate entails longer time to relapse after discontinuation, is similarly tolerable and safe compared to monthly injections of paliperidone palmitate and is beneficial for the caregivers. However, few studies have so far explored in depth the patients' experiences with paliperidone palmitate medication every three months, or with switching from monthly to three-monthly injections of paliperidone palmitate.MATERIAL AND METHODS: A qualitative study based on individual interviews with persons with schizophrenia who receive three-monthly paliperidone palmitate in Norway, Sweden and Denmark. Data was analysed according to qualitative content analysis.RESULTS: Twenty-four patients, 16 men and 8 women, took part in individual interviews. The patients' mental health care professionals mainly recommended the switch to three-monthly paliperidone palmitate, and few or no disadvantages were described. According to the patients, three-monthly paliperidone palmitate had several advantages, such as less frequent injections, less administration and planning and less focus on the illness. In addition, the participants described feeling more stability, being more physically and socially active, and that improvement processes were supported. For some, the use involved practical and economic challenges, and some worried whether the medicine 'wore off' before the next injection. According to the patients, switching to three-monthly paliperidone palmitate did not influence the frequency or content of patients' interaction with health care professionals.CONCLUSION: Switching from monthly to three-monthly injections with paliperidone palmitate seems to be experienced as advantageous for patients with schizophrenia.

Ämnesord

MEDICIN OCH HÄLSOVETENSKAP  -- Klinisk medicin -- Psykiatri (hsv//swe)
MEDICAL AND HEALTH SCIENCES  -- Clinical Medicine -- Psychiatry (hsv//eng)
MEDICIN OCH HÄLSOVETENSKAP  -- Hälsovetenskap -- Omvårdnad (hsv//swe)
MEDICAL AND HEALTH SCIENCES  -- Health Sciences -- Nursing (hsv//eng)

Nyckelord

Psychiatry
Antipsychotic medication
Long-term antipsychotic injections
Mental health
Paliperidone palmitate
Schizophrenia
Service user perspectives

Publikations- och innehållstyp

ref (ämneskategori)
art (ämneskategori)

Hitta via bibliotek

Till lärosätets databas

Kungliga biblioteket hanterar dina personuppgifter i enlighet med EU:s dataskyddsförordning (2018), GDPR. Läs mer om hur det funkar här.
Så här hanterar KB dina uppgifter vid användning av denna tjänst.

 
pil uppåt Stäng

Kopiera och spara länken för att återkomma till aktuell vy